🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

AtriCure, Inc.

ATRC Healthcare
$60.77 +$0.82 (1.36%)
Market Cap: $3.09 B
Gurus Holding
5
Popularity Rank
#1940
% of Shares Held
3.45%
Net Activity (Q2 2026)
+$27.02 M

Guru Ownership Trend

Guru Analysis for AtriCure, Inc. (ATRC)

AtriCure, Inc. (ATRC), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $106.75 M.

Top institutional holders include Steven Cohen and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $27.02 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 191.9%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 24.2%.

Key Holders

Recent Activity Breakdown (Q2 2026)

+$29.11 M
Total Buy Value
New Buys 1
Additions 3
-$2.09 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for AtriCure, Inc. (ATRC)

Major holders include Steven Cohen ($16.91 M), Cliff Asness ($15.22 M), First Eagle Investment ($8.33 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.76 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $27.02 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ATRC. The total reported sell value was $2.09 M.

Yes, 1 managers opened new positions in ATRC, and 3 increased their existing holdings. The total reported buy value was $29.11 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.02% New Buy 604,380 $16.91 M Q2 2026
0.01% Add 191.9% 544,123 $15.22 M Q2 2026
0.01% Add 13.5% 297,643 $8.33 M Q2 2026
0.01% Reduce -24.2% 234,100 $6.55 M Q2 2026
0.01% Add 127.7% 76,307 $2.14 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form